Education
About Us
Working with TipRanks
Follow Us
Summit Therapeutics (SMMT)
NASDAQ:SMMT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 704.29K | $ 1.81M |
| Gross Profit | $ -108.36K | $ -15.01M | $ -2.05M | $ -1.81M | $ 1.81M |
| Operating Income | $ -812.24M | $ 313.00K | $ -89.74M | $ -59.63M | $ -86.19M |
| EBITDA | $ -801.12M | $ -212.85M | $ -69.45M | $ -73.12M | $ -85.91M |
| Net Income | $ -1.08B | $ -221.31M | $ -614.93M | $ -78.78M | $ -88.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 713.45M | $ 412.35M | $ 186.24M | $ 348.61M | $ 71.79M |
| Total Assets | $ 751.18M | $ 435.56M | $ 202.95M | $ 664.17M | $ 113.37M |
| Total Debt | $ 15.50M | $ 7.22M | $ 106.10M | $ 518.76M | $ 2.78M |
| Net Debt | $ -209.76M | $ -97.64M | $ 34.67M | $ 170.16M | $ -69.01M |
| Total Liabilities | $ 92.32M | $ 46.81M | $ 125.26M | $ 537.51M | $ 30.09M |
| Stockholders' Equity | $ 658.86M | $ 388.75M | $ 77.69M | $ 126.65M | $ 83.28M |
| Cash Flow | |||||
| Free Cash Flow | $ -323.59M | $ -142.25M | $ -76.89M | $ -42.21M | $ -72.89M |
| Operating Cash Flow | $ -322.93M | $ -142.11M | $ -76.76M | $ -41.58M | $ -72.59M |
| Investing Cash Flow | $ -174.31M | $ -205.34M | $ -587.77M | $ -624.00K | $ -306.00K |
| Financing Cash Flow | $ 617.53M | $ 381.23M | $ 86.51M | $ 620.24M | $ 77.92M |